共 22 条
- [21] A randomized multicenter phase III study comparing weekly versus every 3 weeks carboplatin (C) plus paclitaxel (P) in patients with advanced ovarian cancer (AOC): Multicenter Italian Trials in Ovarian Cancer (MITO-7)-European Network of Gynaecological Oncological Trial Groups (ENGOT -ov-10) and Gynecologic Cancer Intergroup (GCIG) trial. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
- [22] A randomized multicenter phase III study comparing weekly versus every 3 week carboplatin (C) plus paclitaxel (P) in patients with advanced ovarian cancer (AOC): Multicentre Italian Trials in Ovarian Cancer (MITO-7)-European Network of Gynaecological Oncological Trial Groups (ENGOT-ov-10)-Gynecologic Cancer Intergroup (GCIG) trial. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)